-
A review of ambulatory medical malpractice cases of missed and delayed diagnoses reveals that they result from a witches' brew of multiple breakdowns, cognitive errors, and dysfunctional systems.
-
The FDA has approved an oral, once-daily drug for the treatment of chronic hepatitis B. Telbivudine is the β-L enantiomer of thymidine with potent antiviral activity against hepatitis B virus.
-
There are a number of abnormalities apparent in the 12-lead ECG image. First, the rhythm is not sinus, as upright P waves are not seen in lead II.
-
U.S. HIV providers are bracing themselves for a flood of new HIV patients as hospitals and many doctors respond to the new recommendations by the Centers for Disease Control and Prevention (CDC) of Atlanta, GA, to provide opt-out HIV testing to nearly every patient they see.
-
The Food and Drug Administration (FDA) is warning healthcare professionals regarding the significantly increased risk for serious and life-threatening cardiovascular (CV) complications associated with normalization of hemoglobin levels in patients receiving erythropoiesis-stimulating agents (ESAs).
-
Since 1995, the outlook for patients with HIV infection has improved significantly with the advent of triple-drug-potent antiretroviral (ARV) therapy regimens.
-
Three years of experience using the rapid HIV test have shown New Jersey public health officials that using the rapid test is preferred by clients, and the results are reliable, a recent study shows.
-
HIV clinicians and researchers still are learning how HIV evolves through mutations and development of resistance. If patterns of increasing resistance emerge then this has serious implications for HIV treatment and prevention.
-
Major revisions to the Centers for Disease Control and Prevention (CDC) guidelines for HIV screening are either a boon to the task of identifying the 250,000 Americans who carry the virus but don't know it or a blow to patient autonomy and privacy.
-
The AIDS global epidemic continues to grow, and some countries are seeing a resurgence of infection rates, according to the annual epidemic update by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) in Geneva, Switzerland.
